Investor Overview Press Releases October 10, 2019 Aclaris Therapeutics Announces Divestiture of RHOFADE® October 8, 2019 Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Version of RHOFADE® (oxymetazoline hydrochloride) cream, 1% September 17, 2019 Aclaris Therapeutics to Hold R&D Day View all » Events Sep 27, 20198:00 am EDT Aclaris Therapeutics R&D Day Aug 8, 20195:00 PM EDT Q2 2019 Aclaris Therapeutics Inc. Earnings Conference Call Jul 30, 20195:00 PM EDT Aclaris Presents Top-Line Data from AUAT-201 Oral Phase 2 Trial View all » Feature presentation Immuno-dermatology Pipeline Presentation October 2017
October 8, 2019 Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Version of RHOFADE® (oxymetazoline hydrochloride) cream, 1%
